...
机译:I阶段研究索拉非尼和Tipifarnib用于复发性胶质母细胞瘤:NaBTC 05-02
Univ Calif Los Angeles Dept Neurol 710 Westwood Plaza Reed 1-230 Los Angeles CA 90230 USA;
Univ Calif Los Angeles Dept Neurol 710 Westwood Plaza Reed 1-230 Los Angeles CA 90230 USA;
Dana Farber Canc Inst Boston MA 02115 USA;
NCI Neurooncol Branch Bethesda MD 20892 USA;
Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;
Univ Pittsburgh Pittsburgh PA USA;
Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;
Univ Wisconsin Madison WI USA;
Univ Texas MD Anderson Canc Ctr Dept Neurooncol Houston TX 77030 USA;
Univ Calif San Francisco Dept Neurosurg San Francisco CA USA;
Univ Pittsburgh Pittsburgh PA USA;
Baptist Hlth South Florida Coral Gables FL USA;
Univ Texas MD Anderson Canc Ctr Dept Neurooncol Houston TX 77030 USA;
Univ Hlth Ontario Toronto ON Canada;
Natl Canc Inst Canc Therapy Evaluat Program Invest Branch Toronto ON Canada;
NCI Neurooncol Branch Bethesda MD 20892 USA;
Univ Calif San Francisco Dept Neurosurg San Francisco CA USA;
Univ Texas Austin Coll Pharm Austin TX 78712 USA;
Univ Calif Los Angeles Dept Neurol 710 Westwood Plaza Reed 1-230 Los Angeles CA 90230 USA;
Tipifarnib; Sorafenib; Recurrent GBM; Combination study;
机译:I阶段研究索拉非尼和Tipifarnib用于复发性胶质母细胞瘤:NaBTC 05-02
机译:CYP3A诱导的抗癫痫药对索拉非尼暴露的影响:索拉非尼联合每日替莫唑胺在成人胶质母细胞瘤成人中的II期研究结果
机译:CYP3A诱导的抗癫痫药对索拉非尼暴露的影响:索拉非尼联合每日替莫唑胺在成人胶质母细胞瘤成人中的II期研究结果
机译:Sorafenib之外的肝细胞癌中的分子疗法:III期试验失败的课程和新型靶标
机译:复发性胶质母细胞瘤中非编码RNA的计算功能分析
机译:索拉非尼和替非法尼用于复发性胶质母细胞瘤的I期研究:NABTC 05-02
机译:索拉非尼的阶段I / II研究与厄洛替尼用于复发胶质母细胞瘤的一部分,作为3臂顺序应激临床试验的一部分:NABTC 05-02